Company intelligence / Profile preview
Jinsheng Da Ren Tang
Tianjin, Tianjin, Chinaen.jydrt.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Tianjin Pharmaceutical Da Ren Tang Group is a leading, commercial-stage Chinese pharmaceutical company specializing in traditional Chinese medicine. Its product portfolio covers 599 approved medicines in 13 categories with multiple major brands, including over 120 exclusive products and 75 included in the National Essential Medicine Catalogue. Several products are state-protected or considered 'treasure-class' Chinese medicines[1].
- Therapeutic areas
- EndocrinologyRheumatologyGastroenterologyPulmonologyDermatologyCardiovascularOtherOncologyWomen's Health
- Modalities
- Small moleculeBiologicTraditional Chinese medicineHerbal medicine
- Industry
- Pharma
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Jinsheng Da Ren Tang.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jinsheng Da Ren Tang.